Wednesday, February 22, 2017 11:03:38 AM
New York Private Equity Firm Alumina Partners LLC
Vancouver, B.C. and Boston, MA, February 22, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has executed a non-binding term sheet with an institutional investor wishing to invest up to $8M CDN the Company. The agreement provides for a series of private placement offerings (the “Offerings”) to be conducted between the Company and Alumina Partners (Ontario) Ltd. (“Alumina Partners”), a subsidiary of New York’s Alumina Partners LLC, over the course of its 24-month term.
Upon entry into the definitive agreement, the first tranche will close in the amount of $125,000 CDN, with subsequent tranches of up to $1M CDN available to be drawn down at the Company’s election. Each offering will be comprised of Unsecured Convertible Notes (the “Notes”) and Common Share Purchase Warrants, with all securities issued in connection with each offering bearing a restrictive legend for four months and a day from the date of issue.
“We were impressed by the quality and pace of the ongoing clinical research supporting Imagin’s i/Blue system and, unusual for the emerging growth space, by its lofty academic pedigree as well. Jim Hutchens and his team of industry veterans are poised to substantially change the way we approach bladder cancer – the 4th most common cancer among men and by far the most expensive to treat,” explained Adi Nahmani, Managing Member of Alumina Partners. “For a company of their size to credibly even have a chance of contributing to the fight against cancer is nothing short of extraordinary. We at Alumina are proud to support innovators like Imagin Medical, and we look forward to seeing what they accomplish in the year to come.”
Please find attached the complete news release.
Thanks for all your support.
If you have any questions please feel free to email me or give me a call.
Link to our website:
http://imaginmedical.com/
All the best,
Bill
Bill Galine
imagin_logo_v2.png
775-737-3292
billgaline@gmail.com
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM